Assessment of Patient Sociodemographic Variables in Clinical Trials - Can Patient Characteristics Make a Difference?

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 5, 2000, Pages 570-575

  Connolly, M ^a,c   Low, T ^b  

^a Covance Health Economics ^*  (Australia)

^b GLENEAGLES HOSPITAL   (Singapore)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

Compliance; Generalisability; Randomised controlled trial; Recruitment; Socioeconomic status (SES)

Indexed keywords

CLINICAL TRIAL; EPIDEMIOLOGY; HUMAN; PATIENT SELECTION; REVIEW; SOCIAL CLASS;

CLINICAL TRIALS; HUMANS; PATIENT SELECTION; SELECTION BIAS; SOCIAL CLASS;

EID: 0034266476     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Threats to applicability of randomised trials: exclusions and selective participation. J Health Services Res Policy 1999; 4:112-21.
2. Gorkin L, Schron E, Brooks M, Wiklund I, Kellen J, Verter J, et al. Clinical Trial Enrollers vs. Nonenrollers: The Cardiac Arrhythmia Suppression Trial (CAST) and Enrollment Assessment in Clinical Trials (REACT) Project. Control Clin Trials 1996; 17:46-59.
3. Hart S C, Thong YH. Sociodemographic and motivational characteristics of parents who volunteer their children for clinical research: a controlled clinical trial. BMJ 1990; 300:1372-5.
4. Lovato L C, Hill K, Hertert S, Hunninghake D B, Probstfield J L. Recruitment for Controlled Clinical Trials: Literature summary and annotated bibliography. Control Clin Trials 1997; 18:328-57.
5. Mettlin C, Cummings K M, Walsh D. Risk factor and behavioral correlates of willingness to participate in cancer prevention trials. Nutri Cancer 1985; 7:189-98.
6. Rapport M H, Frevert T, Babior S, Seymour S, Zisook S, Kelsoe J, et al. Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety. Anxiety 1996; 2:117-22.
7. Roberson N. Clinical trial participation, viewpoints from racial/ethnic groups. Cancer Suppl 1994; 9:2687-91.
8. Schwartz C E, Fox B H. Who says yes? Identifying selection biases in a psychosocial intervention study of multiple sclerosis. Soc Sci Med 1995; 40:359-70.
9. Svensson G K. Representation of American Blacks in clinical trials of new drugs. JAMA 1989; 261:263-5.
10. The Lipid Research Clinics Program. The lipid characteristics of participants in the lipid research clinics coronary primary prevention trial. J Chronic Dis 1983; 36:467-79.
11. Gorelick P B, Harris Y, Burnett B, Bonecutter F J. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS). J Natl Med Assoc 1998; 90:141-5.
12. Mouton C P, Harris S, Rovi S, Solorzano P, Johnson M S. Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc 1997; 89:721-7.
13. Apter AJ, Reisine S T, Affleck G, Barrows E, ZuWallack R I. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med 1998; 157:1810-7.
14. Collins J F, Bingham S F, Williford W O, Weiss D G. Who drops out of clinical trials - The VA Cooperative Study Experience [abstract]. Control Clin Trials 1981; 2:78.
15. Gallager J E, Viscoli C M, Horowitz R I. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993; 270:742-4.
16. Ganz P A, Day R, Constantino J. Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial. Stat Med 1998; 17:613-22.
17. Gibaldi M. Failure to comply: A therapeutic dilemma and the bane of clinical trials. J Clin Pharmacol 1996; 36:674-82.
18. Goldman A I, Holcomb R, Perry H M, Schnaper H W, Fitz A E, Frohlich E D. Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administration, National Heart, Lund and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension. Control Clin Trials 1982; 3:75-89.
19. Besch L. Compliance in clinical trials. AIDS 1995; 9:1-10.
20. Neaton J D, Grimm R H, Cutler J A, for the MRFIT Research Group. Recruitment of Participants for the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials 1987; 8:41S-53S.
21. Orr P R, Blackhurst D W, Hawkins B S, for the Macular Photocoagulation Study Group. Patient and clinic factors predictive of missed visits and inactive status in a multicenter clinical trial. Control Clin Trials 1992; 13:40-9.
22. Turner J T, Wright E, Mendella L, Anthonisen N, and the IPPB Study Group. Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest 1995; 108:394-400.
23. Baquet C R, Horm J W, Gibbs T, Greenwald P. Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst 1991; 83:551-6.
24. Baumer J H, Hunt L P, Shield J P H. Social disadvantage, family composition, and diabetes mellitus: prevalence and outcome. Arch Dis Child 1998; 79:427-30.
25. Chaturvedi N, Jarrett J, Shipley M J, Fuller J H. Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall Study and the WHO Multinational Study of Vascular Disease in Diabetes. BMJ 1998; 316:100-6.
26. Kaplan G A, Keil JE. Socioeconomic factors and cardiovascular disease: A review of the literature. Circulation 1993; 88:1973-98.
27. Ruberman W, Weinblatt E, Goldberg J D. Chaudary B S. Psychosocial influences on mortality after myocardial infarction. N Engl J Med 1984; 311:552-9.
28. Smith G D, Hart C, Blane D, Gillis C, Hawthorne V. Lifetime socioeconomic position and mortality: prospective observational study. BMJ 1997; 314:547-52.
29. Winkleby M A, Jatulis D E, Frank E, Fortmann S P. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health 1992; 82:816-20.
30. Alter D A, Naylor C D, Austin P, Tu J V. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999; 341:1359-67.
31. Cai W W, Marks J S, Chen C H, Zhuang Y X, Morris L, Harris J R. Increase Caesarean section rates and emerging patterns of health insurance in Shanghai, China. Am J Public Health 1998; 88:777-80.
32. Chiang T L. Economic transition and changing relation between income inequity and mortality in Taiwan: regression analysis. BMJ 1999; 319:1162-5.
33. Ellaway A, Wood S, MacIntyre P. Someone to talk to? The role of loneliness as a factor in the frequency of GP consultations. Br J Gen Pract 1999; 49:328-57.
34. Foreman S E, Yu L C, Barley D, Chen L W. Use of health services by Chinese elderly in Beijing. Med Care 1998; 36:1265-82.
35. Joung I A, van der Meer J B W, Mackenbach J P. Marital status and health care utilization. Intern J Epidemiol 1995; 24:569-75.
36. Keating N L, Cleary P D, Rossi A S, Zaslavsky A M, Ayanian J Z. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999; 130:545-53.
37. Lai H, Lai S, Krongrad S, Trapido E, Page J B, McCoy C B. The effect of marital status on survival in late-stage cancer patients: An analysis based on surveillance, epidemiology, and end results (SEER) data, in the United States. Int J Behav Med 1999; 2:150-76.
38. Shatin D, Levin R, Ireys H T, Haller V. Health care utilisation by children with chronic illnesses: a comparison of Medicaid and employer-insured managed care. Pediatrics 1998; 102:e44.
39. Pincus T, Esther R, DeWalt D A, Callahan L F. Social condition and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998; 129:406-11.
40. Van der Meer J B W, Mackenbach J P. The care and course of diabetes: differences according to level of education. Health Policy 1999; 46: 127-41.
41. Wan G J, Counte M A, Cella D F, Hernandez L, Deasy S, Shiomoto G. An analysis of the impact of demographic, clinical, and social factors on health-related quality of life. Value in Health 1999; 4:308-18.
42. Cella D F, Orav E J, Kornblith A B, Holland J C, Silberfarb P M, Lee K W, et al. Socioeconomic status and cancer survival. J Clin Oncol 1991; 9:1500-9.
43. Gorkin L, Schron E B, Brooks M M, Wiklund I, Kellen J, Verter J, et al. Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial (CAST-1). Am J Cardiol 1993; 71:263-7.
44. Nattinger A B, McAuliffe T L, Schapira M M. Generalizability of the surveillance, epidemiology, and end results registry population: Factors relevant to epidemiologic and health care research. J Clin Epidemiol 1997; 50:939-45.
45. Bergstrand R, Vedin A, Wilhelmsson C, Wilhelmsen L. Bias due to non-participation and heterogeneous sub-groups in population surveys. J Chronic Dis 1983; 36:725-8.
46. Connolly V, Kesson C M. Socio-economic status and membership of the British Diabetic Association. Diabetic Med 1996; 13:898-901.